home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/d3e42faa-07cc-4d13-bbf9-dde5c60baf5a_Axtria-Insights-Growing-Attention-Being-Paid-to-Pharma-Company-Rebates-and-Discounts.pdf
whitepaper
SHARESHARESHARE
GROWING ATTENTION BEING PAID TO PHARMA COMPANY REBATES AND DISCOUNTS
Drug company rebates and discounts have always been an opaque aspect of the US pharma industry. There is little transparency in how much drug companies pay in rebates and discounts. Indications are it is annually in the tens of billions of dollars for the industry and growing. Price concessions can significantly vary by individual company depending on the portfolio mix and individual therapy class competition facing each drug. Also, growing rebates and drug discounts are greatly affecting biopharma company margins, illustrating the managed care influence of PBMs. DOWNLOAD